255 related articles for article (PubMed ID: 9403633)
1. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation.
Weber KT
Circulation; 1997 Dec; 96(11):4065-82. PubMed ID: 9403633
[No Abstract] [Full Text] [Related]
2. Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
Jugdutt BI; Idikio H; Uwiera RR
Mol Cell Biochem; 2007 Sep; 303(1-2):27-38. PubMed ID: 17426929
[TBL] [Abstract][Full Text] [Related]
3. The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.
Wang J; He W; Guo L; Zhang Y; Li H; Han S; Shen D
Mol Med Rep; 2017 Aug; 16(2):1973-1981. PubMed ID: 28656296
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.
Pfeffer JM; Fischer TA; Pfeffer MA
Annu Rev Physiol; 1995; 57():805-26. PubMed ID: 7778884
[No Abstract] [Full Text] [Related]
5. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
6. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction.
Aronow WS; Ahn C; Kronzon I
Am J Cardiol; 2001 Dec; 88(11):1298-300. PubMed ID: 11728359
[No Abstract] [Full Text] [Related]
7. Left ventricular dysfunction: causes, natural history, and hopes for reversal.
Armstrong PW
Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i15-7:discussion i50. PubMed ID: 10956313
[No Abstract] [Full Text] [Related]
8. The role of renin angiotensin system intervention in stage B heart failure.
Collier P; McDonald KM
Heart Fail Clin; 2012 Apr; 8(2):225-36. PubMed ID: 22405662
[TBL] [Abstract][Full Text] [Related]
9. Heart failure after myocardial infarction: clinical implications and treatment.
Minicucci MF; Azevedo PS; Polegato BF; Paiva SA; Zornoff LA
Clin Cardiol; 2011 Jul; 34(7):410-4. PubMed ID: 21688276
[TBL] [Abstract][Full Text] [Related]
10. Persistence of the prognostic importance of left ventricular systolic function and heart failure after myocardial infarction: 17-year follow-up of the TRACE register.
Kümler T; Gislason GH; Køber L; Torp-Pedersen C
Eur J Heart Fail; 2010 Aug; 12(8):805-11. PubMed ID: 20494923
[TBL] [Abstract][Full Text] [Related]
11. Do angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have similar effects in the improvement of left ventricular dysfunction after myocardial infarction in Japanese?
Miura S; Saku K
Intern Med; 2009; 48(22):1929-30. PubMed ID: 19915291
[No Abstract] [Full Text] [Related]
12. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling.
Kramer CM; Ferrari VA; Rogers WJ; Theobald TM; Nance ML; Axel L; Reichek N
J Am Coll Cardiol; 1996 Jan; 27(1):211-7. PubMed ID: 8522697
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
14. Tissue repair and angiotensin II generated at sites of healing.
Weber KT; Sun Y; Katwa LC; Cleutjens JP
Basic Res Cardiol; 1997 Apr; 92(2):75-8. PubMed ID: 9166984
[No Abstract] [Full Text] [Related]
15. Pathophysiology of heart failure following myocardial infarction.
Struthers AD
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
[TBL] [Abstract][Full Text] [Related]
16. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
[TBL] [Abstract][Full Text] [Related]
17. Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms?
Kokkonen JO; Lindstedt KA; Kovanen PT
Circulation; 2003 May; 107(20):2522-4. PubMed ID: 12777313
[No Abstract] [Full Text] [Related]
18. New concepts in post-infarction ventricular remodeling.
Udelson JE; Patten RD; Konstam MA
Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
[TBL] [Abstract][Full Text] [Related]
19. Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure.
Hanif W; Alex L; Su Y; Shinde AV; Russo I; Li N; Frangogiannis NG
Cardiovasc Pathol; 2017; 30():27-37. PubMed ID: 28759817
[TBL] [Abstract][Full Text] [Related]
20. [Neurohumoral systems escape control. Heart failure symptoms even once--long-term high risk prognosis].
MMW Fortschr Med; 2005 Jul; 147(27-28):45. PubMed ID: 16041943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
